Beijing Hotgen Biotech (SHA:688068) plans to repurchase between 50 million yuan and 100 million yuan of its shares via centralized bidding.
The shares will be bought back for up to 166 yuan per share during the three-month buyback period, according to a Tuesday filing with the Shanghai bourse.
Shares of the biotechnology company were down 2% in recent trade.
CTBC Financial (TPE:2891) unit CTBC Bank will issue NT$9.6 billion in perpetual non-cumulative subordinated financial debentures on June 4, according to a Monday Taiwan Exchange filing.Shares gained about 2% in Tuesday's late morning trade.The 50th series subordinated bonds will carry a fixed annual coupon rate of 4.5% and have no maturity date.The bonds will be issued at face value, with each debenture carrying a denomination of NT$10 million.Proceeds will be used to strengthen its capital structure and replenish working capital.CTBC Bank said the notes may be redeemed after seven years, subject to regulatory approval.
COSCO Shipping Specialized Carriers (SHA:600428) plans to register for issuance up to 5 billion yuan in bonds with a maximum term of 20 years.Proceeds will be used for repaying debts, replenishing working capital, paying ship construction costs and other permitted purposes, according to a Tuesday filing with the Shanghai bourse.The registration is valid for two years.
Infratil's (ASX:IFT, NZE:IFT) fiscal 2026 total proportionate earnings before interest, tax, depreciation, amortization, and fair value adjustments (EBITDAF) of NZ$919.3 million was in line with consensus of NZ$918.3 million, Jefferies said in a note on Tuesday.The company's EBITDAF increased 170% in the fiscal year with contributions from new projects completed in March and April 2025. Development EBITDAF losses of NZ$70 million was better than expected.Infratil swung to a profit of NZ$0.558 per share in fiscal 2026 from a loss of NZ$0.315 a year earlier. Revenue for the 12 months ended March 31 was NZ$3.04 billion, compared with NZ$2.86 billion a year earlier.The investment firm retained its buy rating on Infratil and its price targets of AU$14.40 and NZ$17.30.Infratil's Australian and New Zealand shares were each down 6% in recent Tuesday trade.